Lawsuit challenges CMS’s statutory overreach in its determination to include oral-only phosphate-lowering therapies in the End-Stage Renal Disease Prospective Payment […]
VANCOUVER, British Columbia and CALGARY. Alberta, July 17, 2024 (GLOBE NEWSWIRE) — Methanex Corporation (“Methanex”) (TSX:MX) (NASDAQ:MEOH), one of the […]